The Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis said.
You are here: Home / Top Stories / Dow Jones Newswires: Novartis shares jump after positive result from breast-cancer drug trial
Market News and Views
The Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis said.